P

Inventor

CLARK STEVEN C

US34 patents
⚠️ This page may combine multiple inventors who share the name “CLARK STEVEN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENETICS INST

20 patents
US4675285AJun 23, 1987

Method for identification and isolation of DNA encoding a desired protein

GENETICS INST286 citations99
US5457038AOct 10, 1995

Natural killer stimulatory factor

GENETICS INST121 citations98
US4959455ASep 25, 1990

Primate hematopoietic growth factors IL-3 and pharmaceutical compositions

GENETICS INST513 citations98
US6300478B1Oct 9, 2001

Antibodies to natural killer stimulatory factor

GENETICS INST36 citations96
US5648467AJul 15, 1997

Natural killer cell stimulatory factor

GENETICS INST91 citations96
US4868119ASep 19, 1989

Hematopoietic growth factors

GENETICS INST67 citations96
US5326558AJul 5, 1994

Megakaryocytopoietic factor

GENETICS INST74 citations95
US4877729AOct 31, 1989

Recombinant DNA encoding novel family of primate hematopoietic growth factors

GENETICS INST74 citations95
US4879227ANov 7, 1989

Production of a recombinant human colony stimulating factor

GENETICS INST46 citations93
US7361738B2Apr 22, 2008

Megakaryocyte stimulating factors

GENETICS INST29 citations92
US5648072AJul 15, 1997

Methods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factor

GENETICS INST24 citations92
US4761375AAug 2, 1988

Human interleukin-2 cDNA sequence

GENETICS INST42 citations92
US5032395AJul 16, 1991

Method of inducing leukocytosis with a combination of IL-3 and GM-CSF

GENETICS INST42 citations91
US5414071AMay 9, 1995

Human cytokine IL-9

GENETICS INST24 citations90
US5437863AAug 1, 1995

Method of enhancing the growth of gut epithelial cells by administration of a cytokine such as interleukin II

GENETICS INST19 citations82
US5573763ANov 12, 1996

Family of CSF-l proteins

GENETICS INST13 citations74
US5460810AOct 24, 1995

Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11

GENETICS INST9 citations74
US6348191B1Feb 19, 2002

Production and use of IL-6

GENETICS INST8 citations73
US5569454AOct 29, 1996

Methods of treating infection using natural killer stimulatory factor

GENETICS INST11 citations73
US5639453AJun 17, 1997

Therapeutic uses of IL-3

GENETICS INST4 citations62

NOVARTIS AG

4 patents

INST GENETICS LLC

2 patents

(unassigned)

2 patents

WYETH CORP

2 patents

LUDWIG INST CANCER RES

2 patents

WHITE CONSOLIDATED IND INC

1 patent

AVEO PHARMACEUTICALS INC

1 patent